M&A Deal Summary |
|
|---|---|
| Date | 2019-01-28 |
| Target | Versum Materials |
| Sector | Chemicals |
| Buyer(s) | Merck |
| Deal Type | Add-on Acquisition |
| Deal Value | 5.8B EUR |
| Advisor(s) | Lazard Citizens Capital Markets (Financial) Simpson Thacher & Bartlett (Legal) |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1668 |
| Sector | Diversified |
| Employees | 64,011 |
| Revenue | 21.2B EUR (2024) |
Merck is a science and technology company in healthcare, life science, and performance materials. It develops technologies that improve and enhance life, from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. Merck was founded in 1668 and is based in Darmstadt, Germany.
| DEAL STATS | # |
|---|---|
| Overall | 19 of 26 |
| Sector: Chemicals M&A | 4 of 4 |
| Type: Add-on Acquisition M&A Deals | 15 of 21 |
| State: Pennsylvania M&A | 2 of 2 |
| Country: United States M&A | 8 of 12 |
| Year: 2019 M&A | 1 of 2 |
| Size (of disclosed) | 3 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-10-18 |
Merck KGaA - Flow Cytometry Portfolio
Darmstadt, Germany Merck KGaA - Flow Cytometry Portfolio includes Amnis, the market-leading family of imaging flow cytometry products for cell-based analysis, as well as their Guava portfolio of products, which are economical, high-performance systems based on microcapillary technologies. |
Sell | €63M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-05-06 |
Intermolecular
San Jose, California, United States Intermolecular, Inc. is a provider of a range of advanced materials innovation to industries, including semiconductors, consumer electronics, automotive, and aerospace. Intermolecular was founded in 2004 and is based in San Jose, California. |
Buy | $62M |
